|
2025-02-28 |
2025-02-28 |
PS
Planned sale
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
Officer
|
1,938
-20.1%
34.00
USD 65,892
|
1,938
-20.1%
|
34.00
|
USD 65,892
|
|
|
2025-02-25 |
2025-02-25 |
PS
Planned sale
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
Officer
|
3,743
-32.7%
35.26
USD 131,978
|
3,743
-32.7%
|
35.26
|
USD 131,978
|
|
|
2025-02-20 |
2025-02-20 |
PS
Planned sale
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
Officer
|
1,327
-14.7%
35.69
USD 47,361
|
1,327
-14.7%
|
35.69
|
USD 47,361
|
|
|
2025-02-14 |
2025-02-13 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
108,833
-65.3%
36.02
USD 3,920,001
|
108,833
-65.3%
|
36.02
|
USD 3,920,001
|
|
|
2025-02-14 |
2025-02-13 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
35,586
-17.6%
34.02
USD 1,210,696
|
35,586
-17.6%
|
34.02
|
USD 1,210,696
|
|
|
2025-02-14 |
2025-02-12 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
33,108
-36.4%
33.27
USD 1,101,470
|
33,108
-36.4%
|
33.27
|
USD 1,101,470
|
|
|
2025-02-14 |
2025-02-12 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
171,813
-65.4%
32.69
USD 5,616,808
|
171,813
-65.4%
|
32.69
|
USD 5,616,808
|
|
|
2025-01-31 |
2025-01-30 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
100,918
-69.5%
32.05
USD 3,234,382
|
100,918
-69.5%
|
32.05
|
USD 3,234,382
|
|
|
2024-12-09 |
2024-12-09 |
PS
Planned sale
|
LAURENCIN CATO T
Non-Executive Director
|
2,691
-10.5%
31.85
USD 85,708
|
2,691
-10.5%
|
31.85
|
USD 85,708
|
|
|
2024-12-09 |
2024-12-09 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
61,151
-56.2%
32.07
USD 1,961,406
|
61,151
-56.2%
|
32.07
|
USD 1,961,406
|
|
|
2024-12-05 |
2024-12-05 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
9,221
-13.4%
31.50
USD 290,462
|
9,221
-13.4%
|
31.50
|
USD 290,462
|
|
|
2024-12-04 |
2024-12-04 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
14,349
-17.2%
30.77
USD 441,550
|
14,349
-17.2%
|
30.77
|
USD 441,550
|
|
|
2024-11-27 |
2024-11-27 |
PS
Planned sale
|
Nichols Christian Todd
SVP, Chief Commercial Officer
Officer
|
5,208
-7.9%
29.15
USD 151,813
|
5,208
-7.9%
|
29.15
|
USD 151,813
|
|
|
2024-11-12 |
2024-11-11 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
58,996
-41.5%
30.08
USD 1,774,576
|
58,996
-41.5%
|
30.08
|
USD 1,774,576
|
|
|
2024-11-06 |
2024-11-06 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
10,471
-9.5%
29.53
USD 309,169
|
10,471
-9.5%
|
29.53
|
USD 309,169
|
|
|
2024-03-18 |
2024-03-18 |
PS
Planned sale
|
Nichols Christian Todd
SVP, Chief Commercial Officer
Officer
|
10,417
-13.6%
28.10
USD 292,740
|
10,417
-13.6%
|
28.10
|
USD 292,740
|
|
|
2024-02-27 |
2024-02-27 |
S
Sale
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
Officer
|
2,559
-24.9%
29.65
USD 75,874
|
2,559
-24.9%
|
29.65
|
USD 75,874
|
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
LAURENCIN CATO T
Non-Executive Director
|
2,690
-15.1%
31.85
USD 85,677
|
2,690
-15.1%
|
31.85
|
USD 85,677
|
|
|
2023-06-08 |
2023-06-08 |
PS
Planned sale
|
LAURENCIN CATO T
Non-Executive Director
|
2,638
-26.1%
31.85
USD 84,020
|
2,638
-26.1%
|
31.85
|
USD 84,020
|
|
|
2023-06-07 |
2023-06-07 |
PS
Planned sale
|
LAURENCIN CATO T
Non-Executive Director
|
2,800
-27.2%
31.50
USD 88,200
|
2,800
-27.2%
|
31.50
|
USD 88,200
|
|
|
2023-05-30 |
2023-05-30 |
PS
Planned sale
|
Nichols Christian Todd
SVP, Chief Commercial Officer
Officer
|
27,134
-39.8%
28.93
USD 784,862
|
27,134
-39.8%
|
28.93
|
USD 784,862
|
|
|
2023-05-10 |
2023-05-09 |
PS
Planned sale
|
Wysenski Nancy
Non-Executive Director
|
41,250
-72.3%
31.24
USD 1,288,786
|
41,250
-72.3%
|
31.24
|
USD 1,288,786
|
|
|
2022-11-16 |
2022-11-14 |
B
Purchase
|
Daglio David Angelo Jr.
Non-Executive Director
|
35,000
+77.8%
23.31
USD 815,735
|
35,000
+77.8%
|
23.31
|
USD 815,735
|
|
|
2022-06-21 |
2022-06-21 |
PS
Planned sale
|
Nichols Christian Todd
SVP, Chief Commercial Officer
Officer
|
7,474
-26.2%
28.26
USD 211,203
|
7,474
-26.2%
|
28.26
|
USD 211,203
|
|
|
2022-05-19 |
2022-05-17 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
50,000
-17.7%
29.15
USD 1,457,475
|
50,000
-17.7%
|
29.15
|
USD 1,457,475
|
|
|
2022-05-12 |
2022-05-10 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
25,000
-9.7%
27.22
USD 680,380
|
25,000
-9.7%
|
27.22
|
USD 680,380
|
|
|
2022-05-06 |
2022-05-06 |
S
Sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
93,747
-8.8%
27.85
USD 2,611,313
|
93,747
-8.8%
|
27.85
|
USD 2,611,313
|
|
|
2022-05-06 |
2022-05-05 |
S
Sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
32,288
-3.3%
28.59
USD 923,227
|
32,288
-3.3%
|
28.59
|
USD 923,227
|
|
|
2022-05-06 |
2022-05-05 |
S
Sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
221,222
-18.5%
27.95
USD 6,183,243
|
221,222
-18.5%
|
27.95
|
USD 6,183,243
|
|
|
2022-05-03 |
2022-05-03 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
25,000
-9.7%
28.62
USD 715,415
|
25,000
-9.7%
|
28.62
|
USD 715,415
|
|
|
2022-05-03 |
2022-05-02 |
PS
Planned sale
|
Cooke Shane
Non-Executive Director
|
10,000
-10.0%
29.23
USD 292,330
|
10,000
-10.0%
|
29.23
|
USD 292,330
|
|
|
2022-04-27 |
2022-04-25 |
PS
Planned sale
|
Cooke Shane
Non-Executive Director
|
10,000
-10.0%
27.88
USD 278,849
|
10,000
-10.0%
|
27.88
|
USD 278,849
|
|
|
2022-04-22 |
2022-04-20 |
PS
Planned sale
|
Jackson Blair Curtis
EVP, Chief Operating Officer
Officer
|
49,999
-36.3%
29.61
USD 1,480,335
|
49,999
-36.3%
|
29.61
|
USD 1,480,335
|
|
|
2022-04-19 |
2022-04-18 |
PS
Planned sale
|
Cooke Shane
Non-Executive Director
|
10,000
-10.0%
28.88
USD 288,750
|
10,000
-10.0%
|
28.88
|
USD 288,750
|
|
|
2022-04-12 |
2022-04-11 |
PS
Planned sale
|
Cooke Shane
Non-Executive Director
|
10,000
-10.0%
29.26
USD 292,601
|
10,000
-10.0%
|
29.26
|
USD 292,601
|
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
Cooke Shane
Non-Executive Director
|
10,000
-10.0%
28.18
USD 281,845
|
10,000
-10.0%
|
28.18
|
USD 281,845
|
|
|
2022-03-08 |
2022-03-04 |
B
Purchase
|
snyderman nancy lynn MD
Non-Executive Director
|
427
+4.8%
23.43
USD 10,005
|
427
+4.8%
|
23.43
|
USD 10,005
|
|
|
2022-02-24 |
2022-02-23 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
11,983
-40.0%
24.76
USD 296,650
|
11,983
-40.0%
|
24.76
|
USD 296,650
|
|
|
2022-02-23 |
2022-02-18 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
2,306
-19.5%
25.17
USD 58,042
|
2,306
-19.5%
|
25.17
|
USD 58,042
|
|
|
2021-06-11 |
2021-06-10 |
PS
Planned sale
|
DIXON WENDY L
Non-Executive Director
|
25,000
-37.7%
25.00
USD 625,000
|
25,000
-37.7%
|
25.00
|
USD 625,000
|
|
|
2021-06-11 |
2021-06-09 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
882
-100.0%
24.60
USD 21,697
|
882
-100.0%
|
24.60
|
USD 21,697
|
|
|
2021-06-08 |
2021-06-07 |
PS
Planned sale
|
Gaffin David Joseph
SVP, CLO, Alkermes, Inc.
Officer
|
13,500
-15.3%
24.00
USD 324,000
|
13,500
-15.3%
|
24.00
|
USD 324,000
|
|
|
2021-06-08 |
2021-06-07 |
PS
Planned sale
|
ANSTICE DAVID W
Non-Executive Director
|
5,000
-6.4%
24.00
USD 120,000
|
5,000
-6.4%
|
24.00
|
USD 120,000
|
|
|
2021-05-19 |
2021-05-18 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
150,000
-15.9%
21.90
USD 3,285,405
|
150,000
-15.9%
|
21.90
|
USD 3,285,405
|
|
|
2021-05-14 |
2021-05-14 |
PS
Planned sale
|
Gaffin David Joseph
SVP, CLO, Alkermes, Inc.
Officer
|
2,250
-2.9%
22.23
USD 50,018
|
2,250
-2.9%
|
22.23
|
USD 50,018
|
|
|
2021-05-14 |
2021-05-13 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
25,000
-10.3%
22.39
USD 559,695
|
25,000
-10.3%
|
22.39
|
USD 559,695
|
|
|
2021-05-12 |
2021-05-11 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
60,297
-7.1%
22.30
USD 1,344,798
|
60,297
-7.1%
|
22.30
|
USD 1,344,798
|
|
|
2021-05-12 |
2021-05-11 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
89,703
-9.5%
21.95
USD 1,968,541
|
89,703
-9.5%
|
21.95
|
USD 1,968,541
|
|
|
2021-05-04 |
2021-05-03 |
PS
Planned sale
|
Jackson Blair Curtis
EVP, Chief Operating Officer
Officer
|
34,503
-33.6%
22.18
USD 765,156
|
34,503
-33.6%
|
22.18
|
USD 765,156
|
|
|
2021-04-16 |
2021-04-15 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
28,920
-100.0%
19.72
USD 570,288
|
28,920
-100.0%
|
19.72
|
USD 570,288
|
|
|
2020-10-02 |
2020-10-01 |
PS
Planned sale
|
MITCHELL PAUL J
Non-Executive Director
|
20,000
-74.1%
16.61
USD 332,262
|
20,000
-74.1%
|
16.61
|
USD 332,262
|
|
|
2020-10-05 |
2020-09-28 |
PS
Planned sale
|
ANSTICE DAVID W
Non-Executive Director
|
17,832
-20.7%
16.79
USD 299,310
|
17,832
-20.7%
|
16.79
|
USD 299,310
|
|
|
2020-05-14 |
2020-05-14 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
75,000
-9.0%
15.00
USD 1,125,233
|
75,000
-9.0%
|
15.00
|
USD 1,125,233
|
|
|
2020-05-14 |
2020-05-13 |
PS
Planned sale
|
Brown Iain Michael
SVP Finance & CAO, Alks Inc.
Officer
|
6,250
-13.9%
15.39
USD 96,193
|
6,250
-13.9%
|
15.39
|
USD 96,193
|
|
|
2020-05-14 |
2020-05-12 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
18,000
-8.2%
15.75
USD 283,469
|
18,000
-8.2%
|
15.75
|
USD 283,469
|
|
|
2020-05-07 |
2020-05-07 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
50,000
-6.2%
14.63
USD 731,265
|
50,000
-6.2%
|
14.63
|
USD 731,265
|
|
|
2020-05-07 |
2020-05-05 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
25,000
-11.0%
14.06
USD 351,425
|
25,000
-11.0%
|
14.06
|
USD 351,425
|
|
|
2020-04-03 |
2020-04-02 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
50,000
-6.2%
13.79
USD 689,500
|
50,000
-6.2%
|
13.79
|
USD 689,500
|
|
|
2020-03-26 |
2020-03-26 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
75,000
-9.0%
14.36
USD 1,077,225
|
75,000
-9.0%
|
14.36
|
USD 1,077,225
|
|
|
2020-03-26 |
2020-03-24 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
25,000
-11.0%
13.91
USD 347,718
|
25,000
-11.0%
|
13.91
|
USD 347,718
|
|
|
2020-03-19 |
2020-03-19 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
15,986
-2.1%
15.04
USD 240,393
|
15,986
-2.1%
|
15.04
|
USD 240,393
|
|
|
2020-03-19 |
2020-03-19 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
48,668
-5.9%
14.51
USD 706,168
|
48,668
-5.9%
|
14.51
|
USD 706,168
|
|
|
2020-03-19 |
2020-03-19 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
10,346
-1.2%
13.42
USD 138,867
|
10,346
-1.2%
|
13.42
|
USD 138,867
|
|
|
2020-03-19 |
2020-03-17 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
2,700
-1.3%
14.26
USD 38,504
|
2,700
-1.3%
|
14.26
|
USD 38,504
|
|
|
2020-03-19 |
2020-03-17 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
22,300
-9.8%
13.45
USD 300,002
|
22,300
-9.8%
|
13.45
|
USD 300,002
|
|
|
2020-02-25 |
2020-02-24 |
B
Purchase
|
Wysenski Nancy
Non-Executive Director
|
6,940
+161.3%
19.65
USD 136,371
|
6,940
+161.3%
|
19.65
|
USD 136,371
|
|
|
2019-11-15 |
2019-11-14 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
100,000
-12.2%
19.50
USD 1,950,000
|
100,000
-12.2%
|
19.50
|
USD 1,950,000
|
|
|
2019-11-15 |
2019-11-13 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
|
20,000
-9.8%
19.70
USD 394,056
|
20,000
-9.8%
|
19.70
|
USD 394,056
|
|
|
2019-11-08 |
2019-11-08 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
30,205
-4.0%
19.73
USD 595,827
|
30,205
-4.0%
|
19.73
|
USD 595,827
|
|
|
2019-11-08 |
2019-11-07 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
69,795
-8.9%
19.81
USD 1,382,618
|
69,795
-8.9%
|
19.81
|
USD 1,382,618
|
|
|
2019-11-08 |
2019-11-06 |
PS
Planned sale
|
LANDINE MICHAEL J
SVP, Corp Dev., Alkermes, Inc.
Officer
|
20,000
-9.8%
19.76
USD 395,116
|
20,000
-9.8%
|
19.76
|
USD 395,116
|
|
|
2019-09-23 |
2019-09-19 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
100,000
-12.2%
21.54
USD 2,153,550
|
100,000
-12.2%
|
21.54
|
USD 2,153,550
|
|
|
2019-09-13 |
2019-09-12 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
100,000
-12.2%
22.68
USD 2,268,220
|
100,000
-12.2%
|
22.68
|
USD 2,268,220
|
|
|
2019-09-06 |
2019-09-05 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
100,000
-12.2%
20.18
USD 2,017,830
|
100,000
-12.2%
|
20.18
|
USD 2,017,830
|
|
|
2019-05-24 |
2019-05-23 |
PS
Planned sale
|
POPS RICHARD F
Director and CEO, Alkermes plc
Executive Director
|
50,000
-6.5%
24.22
USD 1,211,150
|
50,000
-6.5%
|
24.22
|
USD 1,211,150
|
|
